BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster

Tiger Newspress2021-08-12

BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.

BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.

The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.

There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.

BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.

The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.

Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • Hsc
    2021-08-15
    Hsc
    Nice
  • wallstreaks
    2021-08-13
    wallstreaks
    Yeah
  • JasminC
    2021-08-13
    JasminC
    加油了!!
  • YauDK
    2021-08-13
    YauDK
    Oh ye ye pls like and comment 
    • Nez
      Done pls like and comment too
  • sunshine138
    2021-08-13
    sunshine138
    Why PFE not charge like a bull.Becoz.... Up 0.01 cents each time.... So freaking slow
  • Yuyu1988
    2021-08-13
    Yuyu1988
    Good news ! 
发表看法
63